✦ LIBER ✦

Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma

✍ Scribed by Fiona Moss; Lynda G. Bobrow; Mary N. Sheppard; Meryl Griffiths; Deborah Rowe; Peter C. L. Beverley; Bruce Addis; Robert L. Souhami

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 650 KB
Volume: 149
Category: Article
ISSN: 0022-3417
DOI: 10.1002/path.1711490205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromogranin A gene expression in non-sm

Chromogranin A gene expression in non-small cell lung carcinomas

✍ Abbona, Giancarlo; Papotti, Mauro; Viberti, Laura; Macr??, Luigia; Stella, Anna; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

Evidence for the existence of neuroendocrine (NE) differentiation in non-small cell lung carcinomas (NSCLCs) is at present based on histochemical, ultrastructural, and immunohistochemical data. The aim of this study was to investigate the extent of NE differentiation in NSCLCs as revealed by mRNA an

Laminin receptor expression and function

Laminin receptor expression and function in small-cell lung carcinoma

✍ Rita Pellegrini; Stefania Martignone; Sylvie Ménard; Maria Ines Colnaghi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 545 KB

Expression of mage genes by non-small-ce

Expression of mage genes by non-small-cell lung carcinomas

✍ P. Weynants; B. Lethé; F. Brasseur; M. Marchand; T. Boon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 574 KB

## Human gene MAGE-I codes for an antigen that is recognized on melanoma cells by autologous cytolytic T lymphocytes (CTL). This antigen is potentially useful as a target for cancer immunotherapy because gene MAGE-I is not expressed in any normal tissues except the testis. We tested 46 surgical sa

The 17-1A antigen is expressed on primar

The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells

✍ Bernward Passlick; Wulf Sienel; Rita Seen-Hibler; Werner Wöckel; Olaf Thetter; K 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 294 KB 👁 1 views

In view of the high incidence of early distant tumor relapses in apparently completely resected (R0, M0) non-small cell lung cancer (NSCLC), there is a need for an adjuvant therapy. Considering the low tumor burden in these patients, an adjuvant therapy with monoclonal antibodies (i.e., the 17-1A MA

Expression of the embryonal neural cell

Expression of the embryonal neural cell adhesion molecule N-CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non-small cell lung cancer

✍ R. E. Kibbelaar; C. E. C. Moolenaar; R. J. A. M. Michalides; D. Bitter-Suermann; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

Urokinase-mediated posttranscriptional r

Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma

✍ Nunzia Montuori; Amalia Mattiello; Alessandro Mancini; Paola Taglialatela; Mario 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 371 KB

## Abstract The urokinase‐type plasminogen activator (uPA) and its cellular receptor (uPAR) are involved in the proteolytic cascade required for tumor cell dissemination and metastasis, and are highly expressed in many human tumors. We have recently reported that uPA, independently of its enzymatic